Free Trial

InterCure (NASDAQ:INCR) Stock Price Down 4.4% - Here's What Happened

InterCure logo with Medical background

InterCure Ltd. (NASDAQ:INCR - Get Free Report) shares were down 4.4% during mid-day trading on Monday . The stock traded as low as $1.52 and last traded at $1.52. Approximately 6,040 shares traded hands during trading, a decline of 80% from the average daily volume of 30,784 shares. The stock had previously closed at $1.59.

InterCure Trading Up 2.0%

The company has a current ratio of 1.78, a quick ratio of 1.15 and a debt-to-equity ratio of 0.15. The firm has a fifty day moving average price of $1.45 and a 200-day moving average price of $1.52.

Institutional Trading of InterCure

An institutional investor recently bought a new position in InterCure stock. Moore Capital Management LP acquired a new position in shares of InterCure Ltd. (NASDAQ:INCR - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 97,273 shares of the company's stock, valued at approximately $156,000. Moore Capital Management LP owned about 0.21% of InterCure as of its most recent SEC filing. Hedge funds and other institutional investors own 8.34% of the company's stock.

InterCure Company Profile

(Get Free Report)

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.

Read More

Should You Invest $1,000 in InterCure Right Now?

Before you consider InterCure, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InterCure wasn't on the list.

While InterCure currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Analysts Are Watching These 4 Penny Stocks—You Should Too
Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines